Company: KAVL
Filing Date: 2025-08-18
Form Type: 424B5
Source: 0001731122-25-001141
Chunk: 19

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-18
Form: 424B5
Chunk 19
---
a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser’s
written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks;
and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the
trading activity in the secondary market for our common stock, and therefore stockholders may have difficulty selling their shares.

<div align='center'>9

USE OF PROCEEDS</div>

We may issue and sell shares of our common stock having aggregate gross proceeds
of up to $1,553,536 from time to time under this prospectus supplement and the accompanying base prospectus. Because there is no minimum
offering amount required as a condition of this offering, the actual total offering amount, commissions and proceeds to us, if any, are
not determinable at this time. The amount of proceeds from this offering will depend upon the number of shares of our common stock sold
and the market price at which they are sold. There can be no assurance that we will be able to sell any shares of our common stock under
or fully utilize the Sales Agreement with Maxim as a source of financing.

We intend to use the net proceeds, if any, from the
sales of shares of our common stock offered by this prospectus supplement and the accompanying base prospectus for working capital and
general corporate purposes. We have broad discretion in determining how the proceeds of this offering will be used, and our discretion
is not limited by the aforementioned possible uses. Our Board of Directors believes the flexibility in application of the net proceeds
is prudent.

As of the date of this prospectus supplement, we cannot
specify with certainty all of the particular uses for the net proceeds to be received from this offering. The amounts and timing of our
actual expenditures will depend on numerous factors including our operating costs and the amount of funding, if any, received from grants.
Accordingly, our management will have broad discretion in the application of the net proceeds, and investors will be relying on the judgment
of management regarding the application of the net proceeds from the offering. We may find it necessary or advisable to reallocate the
net proceeds of this offering; however, any such reallocation would be substantially limited to the categories set forth above as we do
not intend to use the net proceeds for other purposes. Pending such uses set forth above, we plan to invest the net proceeds in government